OXiGENE to Present at Wells Fargo Securities 2005 HealthCare Conferenc

    Business Editors/Health/Medical Writers
    Wells Fargo Securities 2005 HealthCare Conference
    BIOWIRE2K

    WALTHAM, Mass.--(BUSINESS WIRE)--March 1, 2005--OXiGENE, Inc. (NASDAQ:OXGN, XSSE:OXGN), a leading developer of biopharmaceutical compounds designed to target aberrant blood vessels within solid tumor cancers and ocular neovascular diseases, today announced that President and Chief Executive Officer Fred Driscoll will present at Wells Fargo Securities 2005 HealthCare Conference, at the St. Regis Hotel in New York City, New York. The conference takes place March 1-2.
    The OXiGENE presentation is scheduled to begin at 3:30 pm ET, Wednesday, March 2, 2005. A live and archived webcast will be available on OXiGENE's website, www.oxigene.com. From the home page, click on the "Calendar of Events" link under the tab labeled "Press Room". Please log on five minutes prior to the event to ensure the proper software is downloaded and installed.

    About OXiGENE, Inc.

    OXiGENE is an emerging pharmaceutical company developing novel small-molecule therapeutics to treat cancer and eye diseases. The Company's major focus is the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. OXiGENE is dedicated to leveraging its intellectual property position and therapeutic development expertise to bring life saving and enhancing medicines to patients.

--30--PP/ny*

CONTACT: MacDougall BioCommunications Chris Erdman, 508-647-0209 chris@macbiocom.com

KEYWORD: MASSACHUSETTS INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL BIOTECHNOLOGY TRADESHOW CONFERENCE CALLS SOURCE: OXiGENE, Inc.

Copyright Business Wire 2005